Healthcare Global Enterprises Ltd - Improving ARPOB Led By Operational Efficiency
The oncology industry is projected to grow at 13-14% CAGR over FY24-30E, primarily due to insufficient early-stage diagnoses in India.
306 Views
Healthcare Global Enterprises Ltd - Margins Still Below Industry Levels; ARPOB Improves
Healthcare Global Enterprises (HCG) reported revenue of Rs 487 Cr, up 15.9% YoY, which stood above our expectations. Growth was primarily driven by...
287 Views
Healthcare Global Enterprises Ltd - Margins Still Below Industry Levels
Healthcare Global Enterprises (HCG) reported revenue of Rs 461 Cr, up 12.9% YoY, in line with our expectations. Growth was primarily driven by...
162 Views
Top Picks - Apr 2023
Axis Top Picks basket outperformed the benchmark by a significant margin with its impressive return of 9.7% in FY23 as against the 0.6% decline...
312 Views
Healthcare Global Enterprises Ltd - Margins Still Below Industry Levels
Over the last 4 quarters, the company’s EBITDA margins were flat (range 18.2%) despite a fall in other expenses as expenses are increasing in the...
253 Views